title: [Adjuvant treatment after total prostatectomy].
abstract: Several adjuvant treatments are used after radical prostatectomy. In case of local risk of recurrence, adjuvant radiotherapy decreases the risk of biochemical recurrence but does not improve the overall survival. In case of metastasis risk, adjuvant hormone therapy should be discussed. For positive lymph node patients, LHRH agonists after radical prostatectomy improve overall survival. For pT3 patients with positive surgical margins, non steroid anti androgens improve disease free survival.
authors.affiliation: Institut Bergonié, 229, cours de l'Argonne, 33076 Bordeaux, France. Richaud@bergonie.org
authors.forename: P
authors.initials: P
authors.lastname: Richaud
mesh_terms: D000726:Androgen Antagonists / Q000627:therapeutic use; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D017024:Chemotherapy, Adjuvant; D007987:Gonadotropin-Releasing Hormone / Q000819:agonists; D006801:Humans; D008207:Lymphatic Metastasis; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000628:therapy*; D018714:Radiotherapy, Adjuvant
chemical_list: D000726:Androgen Antagonists; D018931:Antineoplastic Agents, Hormonal; D007987:Gonadotropin-Releasing Hormone